How Lipoprotein Particles Shape Lipid Metabolism and Disease: From Cellular Response Mechanisms to CRISPR KO Models
When the metabolic balance of lipoprotein particles in the blood is disrupted, it triggers chronic inflammation—the common root of atherosclerosis, metabolic syndrome, and even neurodegenerative diseases. Circulating lipoprotein particles are the primary carriers of cholesterol and triglycerides: low-density lipoprotein (LDL) delivers cholesterol to tissues, while high-density lipoprotein (HDL) recycles it via reverse transport. Together, they maintain the delicate balance of lipid metabolism. When this balance is broken—such as through oxidative deposition of LDL or dysfunction of HDL—damage-associated molecular patterns (DAMPs) like oxidized phospholipids (OxPLs) activate innate immune signaling, driving foam cell formation and metabolic inflammation. Pathway enrichment analysis shows that lipoprotein response pathways are significantly enriched in functional genomics (FDR = 1.11×10⁻⁵), further confirming their role as key regulatory hubs. With CRISPR gene editing technology, i...